Innovative Drugs Sold Under the Special Access Programme Can Receive Data Protection in Canada

May 18, 2011

Tags:

Food and Drug Regulatory Intellectual Property Intellectual Property Litigation Litigation and Dispute Resolution Patents Pharmaceuticals

Related Expertise

Related Insights

Ontario introduces COVID-vaccine passport
Canada’s new biomanufacturing and life sciences investment strategy
Important changes ahead for regulation of supplemented foods and labelling of natural health products
Déjà vu: Another delay in implementation of Canada’s PMPRB Regulations
Get your daily dose! Regulatory framework for supplemented foods and updated labelling for natural health products coming to Canada

Back